Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

1. Graybill, W.S.
2. Pardo Búrdalo, B.
3. O'Malley, D.M.
4. Vergote, I.
5. Monk, B.J.
6. Auranen, A.
7. Copeland, L.J.
8. Sabbatini, R.
9. Herzog, T.J.
10. Follana, P.
11. Pothuri, B.
12. Braicu, E.I.
13. McCormick, C.
14. Yubero, A.
15. Moore, R.G.
16. Vuylsteke, P.
17. Raaschou-Jensen, N.
18. York, W.
19. Hartman, J.
20. González-Martín, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/IJGC-2024-005356 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus